MedPath

Role of cervical cancer microbiome during cervical cancer progressio

Not Applicable
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2022/06/043540
Lead Sponsor
Science for Equity Empowerment and Development
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Women within the age group of 21-65 years with or without pre-malignant

2. malignant cervical lesions will be included in the study

Exclusion Criteria

1. Women who are pregnant and /or lactating at the time of the study, women who have undergone hysterectomy adenocarcinoma of the cervix

2. Women who have been diagnosed and have already started treatment for cervical lesions and malignancies will be excluded

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath